Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000899140-21-000349
Filing Date
2021-03-01
Accepted
2021-03-01 17:14:04
Documents
1
Group Members
ALEXANDER J. DENNER, PH.D.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A, AMENDMENT #3 s41267637.htm SC 13D/A 41432
  Complete submission text file 0000899140-21-000349.txt   42928
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Subject) CIK: 0001446847 (see all company filings)

EIN.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85292 | Film No.: 21699266
SIC: 2834 Pharmaceutical Preparations

Mailing Address 660 STEAMBOAT ROAD GREENWICH CT 06830
Business Address 660 STEAMBOAT ROAD GREENWICH CT 06830 203-302-2330
Sarissa Capital Management LP (Filed by) CIK: 0001577524 (see all company filings)

EIN.: 900924432 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A